MORGAN STANLEY PLC/CALL/ZOETIS/300/0.1/16.01.26 | Market Closed - Börse Stuttgart 19:19:34 17/05/2024 BST | ||
| 0.73 EUR | +1.39% |
|
| Current month | +15.87% | ||
| 1 month | +40.38% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
ZOETIS INC.
Latest news about ZOETIS INC.
More news
| Date | Price | Change |
|---|---|---|
| 17/05/24 | 0.73 | +1.39% |
| 16/05/24 | 0.72 | +1.41% |
| 15/05/24 | 0.71 | +2.90% |
| 14/05/24 | 0.69 | -1.43% |
| 13/05/24 | 0.7 | 0.00% |
Delayed Quote Börse Stuttgart
Last update May 17, 2024 at 07:19 pm
More quotesStatic data
| Product type | Plain-Vanilla-Warrants |
|---|---|
| Buy / Sell | CALL |
| Underlying | ZOETIS INC. |
| Issuer | Morgan Stanley |
| WKN | ME5M0J |
| ISIN | DE000ME5M0J3 |
| Date issued | 18/12/2023 |
| Strike | 300 $ |
| Maturity | 16/01/2026 (609 Days) |
| Parity | 10 : 1 |
| Emission price | 0.67 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 1.87 € |
|---|---|
| Lowest since issue | 0.46 € |
| Spread | 0.04 € |
| Spread % | 5.26% |
Company Profile
Zoetis Inc. specializes in developing, manufacturing and marketing of animal health products. Net sales break down by activity as follows:
- pets (64.4%): cats and dogs (94.9% of net sales) and horses (5.1%);
- livestock (34.5%): cattle (51.6% of sales), swine (20.2%), poultry (17.1%), fish (7.6%) and other (3.5%);
- other (1.1%).
Net sales break down by family of products into parasiticides (23%), vaccines (21.3%), dermatological products (16.4%), anti-infectives (13.4%), medical food additives (4.5%), diagnostic products (4.4%) and other (17%).
At the end of 2022, the group has 29 production sites worldwide.
The United States accounts for 53.4% of net sales.
Sector
-
Consensus: Zoetis Inc.
Sell
Buy
Mean consensus
BUY
Number of Analysts
17
Last Close Price
174.1
USD
Average target price
211.2
USD
Spread / Average Target
+21.34%
- Stock Market
- Warrants
- Warrant
